Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
Open Access
- 11 November 2009
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 8 (1) , 253
- https://doi.org/10.1186/1475-2875-8-253
Abstract
Preventing the emergence of anti-malarial drug resistance is critical for the success of current malaria elimination efforts. Prevention strategies have focused predominantly on qualitative factors, such as choice of drugs, use of combinations and deployment of multiple first-line treatments. The importance of anti-malarial treatment dosing has been underappreciated. Treatment recommendations are often for the lowest doses that produce "satisfactory" results.Keywords
This publication has 45 references indexed in Scilit:
- Plasmodium falciparum pfmdr1 Amplification, Mefloquine Resistance, and Parasite FitnessAntimicrobial Agents and Chemotherapy, 2009
- ORIGINAL ARTICLE: Probability of emergence of antimalarial resistance in different stages of the parasite life cycleEvolutionary Applications, 2009
- Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trialThe Lancet, 2008
- Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policiesMalaria Journal, 2008
- Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug ResistanceAntimicrobial Agents and Chemotherapy, 2008
- Deployment of Early Diagnosis and Mefloquine- Artesunate Treatment of Falciparum Malaria in Thailand: The Tak Malaria InitiativePLoS Medicine, 2006
- Prospective Study of One Million Deaths in India: Rationale, Design, and Validation ResultsPLoS Medicine, 2005
- Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2PLoS Medicine, 2005
- Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in miceTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987